Skip to main content
. 2001 Nov;8(6):1115–1119. doi: 10.1128/CDLI.8.6.1115-1119.2001

TABLE 1.

Hib strains used in this study and their corresponding SBA titers obtained with quality control preparations

Hib strain designation SBA titer (50% killing) by antibody source
Sandoglobulin MPR BPIG
GB 3291a 128 1,024 16,384
DR 247 128 2,048 32,768
DR 458b 128 2,048 32,768
DR 519 512 16,384 65,536
DR 671 128 4,096 32,768
DR 715 256 4,096 32,768
DR 729 128 4,096 32,768
DR 761 128 512 16,384
DR 810 128 2,048 32,768
Eagan S-2 mutantc No titer No titer No titer
a

Reference Hib strain (Centers for Disease Control and Prevention) used in the generation of Hib antiserum. 

b

Hib strain from the Dominican Republic used in this study for the determination of SBA titers. 

c

Unencapsulated mutant strain.